1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"The MIKE SLIVE FOUNDATION 2026-2027 Pilot Research Grant" is currently closed and not accepting applications.
The MIKE SLIVE FOUNDATION 2026-2027 Pilot Research Grant is sponsored by Mike Slive Foundation for Prostate Cancer Research. This pilot research grant funds projects focused on prostate cancer research.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Our Research Grant Program – Mike Slive Foundation Our Research Grant Program Our Research Grant Program Anna Slive Harwood 2026-07-06T15:27:09-05:00 Inspired by Mike Slive’s groundbreaking work in college sports, the Foundation has channeled the momentum of his life’s work into the support of pioneering research.
Since our founding in 2017, the Mike Slive Foundation has raised nearly… in the fight against Prostate Cancer That funding has supported twelve unique investigations: Developing Culturally-Tailored Interventions to Increase Prostate Cancer Screening Among African-American Men Targeting the CD24/p53 axis for Lethal Metastatic Prostate Cancer Therapy Impact of Physical and Cognitive Function on Treatment Selection and Outcomes among Older Patients with Prostate Cancer Identification of NCOA6 as a New Oncogenic Driver of Neuroendocrine Prostate Cancer Unveiling the Roles of Neuroendocrine Cells in Prostate Cancer Development Impact of TET Protein with Aggressive Prostate Cancer Solving the Obesity Paradox in Prostate Cancer Novel Functions of Mitochondria Localized Androgen Receptor in Prostate Cancer Targeting the Amino Acid Transporter LAT1 to Treat Aggressive Prostate Cancer Targeted Therapy for Nuclear Receptor Resistance Mechanisms in Prostate Cancer Mechanism of Tumor Immune Escape and Metastasis in Lethal Prostate Cancer PSMA-PET/MRI for Radiation Treatment Planning in Patients with Locally Metastatic Prostate Cancer Guided by our commitment to find a cure for prostate cancer, the Foundation funds pilot grants for innovative research that allows researchers the ability to show proof-of-concept when applying for larger, highly competitive federal grants.
We use a peer-review process designed after the National Institutes of Health’s model to select our grant recipients. In 2019, we expanded the reach of our grant initiative to ten additional states in the Southeast and have plans to expand nationwide in the coming years. 2026 Grant Program Guidelines Be a catalyst for the cure.
With your help, the Mike Slive Foundation will generate national awareness and fund the scientific breakthroughs that will save lives and end prostate cancer. P. O.
Box 530748 Birmingham, AL 35253 info@MikeSliveFoundation. org Thank you for your message. It has been sent.
There was an error trying to send your message. Please try again later.
According to the current listing, eligibility includes: Not explicitly detailed, but generally open to academic and research institutions. Based on other grants of this type, likely targets independent investigators or research teams within universities. Confirm the full requirements in the official notice before applying.
The published deadline was September 7, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
The MIKE SLIVE FOUNDATION 2026-2027 Pilot Research Grant is funded by Mike Slive Foundation for Prostate Cancer Research. Verify program details on the funder's official page before applying.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
The Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articleCDC-RFA-DP-27-0023 puts the National Breast and Cervical Cancer Early Detection Program, the National Comprehensive Cancer Control Program, and the National Program of Cancer Registries into a single competition closing February 5, 2027. Three statutorily separate eligibility pools, one application deadline, and an award count that maps onto the incumbent footprint. Here is how to read that.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read article